1 |
任成山,赵晓晏. 理性和科学的态度认识埃博拉[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(4): 459-462.
|
2 |
任成山,林 辉,杨仕明,等. 冠状病毒及新型冠状病毒肺炎防控策略[J/CD]. 中华肺部疾病杂志(电子版), 2020, 13(1): 1-5.
|
3 |
Wiersinga W Joost, Rhodes Andrew, Cheng Allen C, et al. Pathophysiology,transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review[J]. JAMA, 2020: doi: 10.1001/jama.2020.12839.
|
4 |
Grifoni Alba, Weiskopf Daniela, Ramirez Sydney I, et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals[J]. Cell, 2020, 181 (7): 1489-1501.
|
5 |
Machhi J., Herskovitz J., Senan A. M., et al. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections[J]. J Neuroimmune Pharmacol, 2020: doi: 10.1007/s11481-020-09944-5.
|
6 |
Merad M.Martin J. C.. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages[J]. Nat Rev Immunol, 2020, 20 (6): 355-362.
|
7 |
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies[J]. Biosci Trends, 2020, doi: 10.5582/bst.2020.01047.
|
8 |
Shang Lianhan, Zhao Jianping, Hu Yi, et al. On the use of corticosteroids for 2019-nCoV pneumonia[J]. The Lancet, 2020, 395(10225): 683-684.
|
9 |
World Health Organization. Clinical management of COVID-19, interim guidance, 27 May 2020.
URL
|
10 |
Wu C., Chen X., Cai Y., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China[J]. JAMA Intern Med, 2020: doi: 10.1001/jamainternmed.2020.0994.
|
11 |
Recovery Collaborative Group, Horby P., Lim W. S., et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report[J]. New Engl J Med, 2020: doi: 10.1056/2021436.
|
12 |
Luis C, Alberto B, Francisco ADR, et al. GLUCOCOVID: A controlled trial of methylprednisolone in adults hospitalized with COVID-19 pneumonia[J]. medRxiv, 2020: doi: 10.1101/2020.06.17.20133579.
|